Complications

This article gives a clear, patient-friendly overview of Crohn’s disease: what it is, common symptoms and complications, likely causes, and how doctors diagnose it. That context can help people recognize when to seek...

Based on the title and source metadata, this appears to be a case report related to Crohn's disease and Complications. The original article is from cureus.com.

Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease and Complications. The original article is from physiciansweekly.com.

This analysis suggests people with IBD (Crohn’s disease and ulcerative colitis) are more likely to have periodontitis. Oral health problems can worsen quality of life and may need separate screening or care.

This study suggests LVV can occur in people with IBD at younger ages and with distinct vascular findings, and it may arise even when gut disease is in remission. That matters for awareness, diagnosis, and coordination...

A pooled analysis presented at a medical conference suggests people with IBD—especially ulcerative colitis—may have higher rates of some genitourinary cancers, which could affect discussions about cancer risk and...

This EC approval means ustekinumab (Stelara) is now an authorised treatment option in the EU for certain children and adolescents with moderate–severe Crohn’s disease who have not responded to other treatments.

Based on the title and source metadata, this appears to be a patient education related to Crohn's disease, Inflammatory bowel disease, and Joint Pain. The original article is from msn.com.

Cure8 found this source from hmpgloballearningnetwork.com, but the page could not be read reliably yet. It is tagged for Crohn's disease and Complications. Open the original article for the full details.

This study suggests viral exposures—specifically Epstein–Barr virus—might be associated with later development of Crohn’s disease, which could help researchers study disease triggers. If confirmed, such findings might...

People with Crohn’s often have other inflammatory or immune-related conditions. Knowing these links can help patients and clinicians watch for symptoms that might need evaluation or treatment.

Knowing the range of Crohn’s symptoms helps you recognize when to seek care, track disease patterns, and explain concerns to your clinician. The article highlights location-based differences and serious complications...

Personal stories raise awareness about how Crohn’s disease affects patients and families, and fundraising helps charities that support research and services. The article may resonate with people coping with surgery,...

Women with Crohn’s may have additional or different symptoms (period changes, painful sex, fertility concerns, bone and iron problems) that can affect daily life and long-term health. Recognizing these issues helps guide...

Patients considering switching biologics or clinicians choosing a second‑line therapy may care because the study suggests ustekinumab had better long‑term persistence and improving remission rates compared with anti‑TNF...

Chronic inflammation in Crohn’s, especially when the colon is affected, raises colorectal cancer risk over time. Knowing risk factors and recommended screening helps people with Crohn’s get earlier detection and...

The findings point to an immune-cell change that may happen before Crohn’s symptoms appear, which could help predict relapse or guide future therapies. That could eventually affect monitoring or new treatment strategies...

Reducing long-term corticosteroid use matters because steroids have significant side effects when used repeatedly or chronically. The study suggests ileocaecal resection may lower steroid exposure for many patients, but...

Cure8 found this source from hmpgloballearningnetwork.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Tests and monitoring. Open the original article...

Based on the title and source metadata, this appears to be a clinical study related to Irritable bowel syndrome, Upadacitinib, and JAK inhibitor. The original article is from msn.com.

This study reports that upadacitinib produced clinical responses and steroid-free remission in a majority of patients with refractory Crohn's disease at 12 weeks, which may be relevant for people who have not responded...

People (especially women) with recurrent stomach pain, persistent nausea, or bleeding can be misdiagnosed with IBS when they have inflammatory bowel disease like Crohn’s. Early recognition can prevent complications that...

This is an early positive interim report of a new oral drug (ALK5 inhibitor) aimed at fibrostenosing Crohn’s disease. Treatments that target intestinal strictures are an important area of research for people with...

This report describes an investigational drug that appears to reach its intestinal target and produced molecular changes in biopsies from people with fibrostenosing Crohn’s — a form that causes scarring and strictures.

This study suggests a microbiome‑based biomarker (IgG reactivity to certain gut bacteria, especially M. gnavus) could help identify spondyloarthritis in people with Crohn’s disease and distinguish axial from peripheral...

Cure8 could only read part of this source from health.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Complications.

Based on the title and source metadata, this appears to be a case report related to Crohn's disease, Stricture, and Procedures and surgery. The original article is from cureus.com.

Based on the title and source metadata, this appears to be a biomarker study related to Crohn's disease, Biomarker, and Joint Inflammation. The original article is from msn.com.

The study points to a specific gut microbe, Mediterraneibacter gnavus, that may be linked to joint inflammation in people with Crohn's disease. If confirmed, a microbial biomarker could help identify who is at risk for...

If EBV infection raises Crohn's risk, it could point to new causes and therapeutic targets. Many people with or at risk for IBD will want to know whether viral exposure plays a role in their disease or in prevention...

People with IBD (Crohn’s disease or UC) have a higher risk of blood clots, especially during active disease. Long flights increase clot risk because of prolonged immobility, so the article’s travel-focused precautions...

If EBV exposure increases the risk of later Crohn's disease, it could help explain one environmental trigger for IBD and point to new research directions for prevention or treatment. Patients may be interested because...

Perianal fistulas are a serious, hard-to-treat complication of Crohn disease. Fast Track status may speed development of a new implantable stem cell therapy that aims to close fistulas and promote local healing. Ongoing...

Crohn’s can sometimes cause flare-ups or complications that make working difficult or impossible; disability benefits can replace part of lost income. The article lays out the types of benefits and what the SSA looks for...

The article connects psoriasis and Crohn's disease through shared immune pathways and the gut-skin axis, which may matter because people with one condition could have signs or risks related to the other. It emphasizes...

This meta-analysis suggests people with IBD—especially those with Crohn’s disease—have a modestly increased risk of stroke. That makes cardiovascular risk assessment and prevention potentially more important for people...

Cure8 could only read part of this source from ajmc.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Complications.

The study suggests a surgical change—removing the mesentery during Crohn’s operations—may significantly reduce early recurrence in the intestinal lining, which could mean fewer repeat surgeries and hospital readmissions...

A surgical technique (mesentery removal) reported in an international randomized trial lowered early endoscopic recurrence after Crohn’s surgery. If validated more widely, it could reduce repeat operations and hospital...

Arthralgia and other extraintestinal symptoms may signal higher risk of developing peripheral arthritis in people with Crohn disease. Recognizing early joint pain could prompt closer monitoring or earlier rheumatology...

Crohn’s disease can cause problems beyond the gut that affect bones, skin, eyes, liver, kidneys, joints, and mental health. Knowing these links helps patients and caregivers watch for symptoms and get coordinated care to...

Longer-term data help patients and clinicians understand whether an initial response to a new biologic (mirikizumab) is likely to last and whether safety findings remain acceptable over two years.

Market reports highlight which companies and drug types are investing in Crohn's disease — that can signal upcoming therapies, trial activity, and availability. Mentions of trials (for example anti‑TL1A) may be of...

Cure8 found this source from sciencedirect.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original article for...

People with both psoriasis and hidradenitis suppurativa appear to have higher overall morbidity and a greater observed risk of Crohn’s disease. Genetic findings suggest shared biological pathways that could affect how...

This suggests an existing antibiotic, vancomycin, may help a specific group of IBD patients who also have primary sclerosing cholangitis (PSC), including some who did not respond to other IBD treatments. If confirmed in...

Vulvar Crohn’s is an uncommon but real extraintestinal manifestation that can cause painful skin changes and sometimes appears before GI Crohn’s is diagnosed. Knowing about it may speed diagnosis and lead to coordinated...

This press release reports multi-year clinical trial data suggesting sustained remission and intestinal healing with Omvoh (mirikizumab) in patients with Crohn's disease—information that could affect treatment...